Therapeutic efficacy of lenvatinib in nonviral unresectable hepatocellular carcinoma

AIM: To investigate the therapeutic effect of lenvatinib (LEN) in liver disease etiology, especially nonviral hepatocellular carcinoma (HCC). METHODS AND RESULTS: Sixty‐seven patients with unresectable advanced HCC (u‐HCC) treated with LEN and consisting of 26 hepatitis C virus (HCV), 19 hepatitis B...

Descripción completa

Detalles Bibliográficos
Autores principales: Tomonari, Tetsu, Sato, Yasushi, Tanaka, Hironori, Mitsuhashi, Takeshi, Hirao, Akihiro, Tanaka, Takahiro, Taniguchi, Tatsuya, Okamoto, Koichi, Sogabe, Masahiro, Miyamoto, Hiroshi, Muguruma, Naoki, Takayama, Tetsuji
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wiley Publishing Asia Pty Ltd 2021
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8593789/
https://www.ncbi.nlm.nih.gov/pubmed/34816013
http://dx.doi.org/10.1002/jgh3.12663

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8593789/
https://www.ncbi.nlm.nih.gov/pubmed/34816013
http://dx.doi.org/10.1002/jgh3.12663

Ejemplares similares